To estimate fatality rates due to severe acute respiratory distress syndrome (ARDS) related to COVID‐19 in Brazilian women, comparing pregnant and postpartum women with nonpregnant women.
A cross‐sectional study of 12 566 pregnant and postpartum women (obstetric group) and 90 025 nonpregnant women (nonobstetric group) aged 15–49 years reported with severe ARDS in 2020. The Brazilian ARDS Surveillance System was used to compare the outcome (death or cure) between the groups, considering age, race, or comorbidities.
The mortality rate related to ARDS/COVID‐19 in the obstetric group was 7.8% (377/4853) compared with 13.9% (5946/42 915) in the nonobstetric group. Comorbidity was associated with increased fatality cases for both groups, but higher in the nonobstetric group (22.8% vs 13.3%). In the obstetric group, deaths related to COVID‐19 were concentrated in the third trimester or postpartum period. If comorbidity was present, deaths by COVID‐19 were 4.4 times higher than ARDS due to other etiologies, and twice higher in women who self‐reported as black (13.7%) than white women (6.7%). Considering ADRS etiology, deaths by COVID‐19 were 3.4–6.7 times higher than any other etiology.
ARDS related to COVID‐19 in obstetric patients was an important factor for worse clinical outcomes, with 3–6 times higher death rates than other ARDS etiologies. Pregnant and postpartum women with severe ARDS related to COVID‐19 had a lower fatality rate than nonpregnant women, even with associated comorbidity.
The mortality rate among pregnant and postpartum women with severe acute respiratory distress syndrome due to COVID‐19 in Brazil in 2020 was significant but lower than in nonpregnant women.
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.